What Is Proteomics?

Proteomics is a field of molecular biology concerned with the large-scale identification, quantification, and functional characterization of all proteins expressed by a genome, cell, tissue, or organism at a given time and under a given set of conditions. The word was coined in the mid-1990s by analogy with genomics, the study of the complete set of genes, recognizing that the proteome (the full complement of proteins) is a more direct representation of cellular function than the genome alone. Unlike the genome, which is relatively static, the proteome is highly dynamic: protein expression levels, modifications, and interactions change in response to development, disease, environmental stimuli, and therapeutic intervention, making proteomics a powerful tool for understanding biology and for identifying biomarkers and drug targets.

The field draws on analytical chemistry, mass spectrometry, bioinformatics, and cell biology. Proteomics datasets are among the most complex in the life sciences, combining the chemical diversity of protein sequences with post-translational modifications, splice variants, and protein complexes that cannot be inferred directly from gene sequences. Computational tools for database searching, statistical analysis, and pathway mapping are as central to proteomics as the experimental instrumentation.

Mass Spectrometry-Based Proteomics

Mass spectrometry is the dominant analytical technology in proteomics because of its sensitivity, speed, and ability to identify proteins from complex mixtures without prior knowledge of which proteins are present. In a typical shotgun proteomics experiment, proteins are extracted from a biological sample, digested with a protease such as trypsin into peptide fragments, separated by liquid chromatography, and introduced into a mass spectrometer that measures the mass-to-charge ratios of the peptides and their fragmentation products. Database search algorithms then match the fragment ion spectra against theoretical spectra derived from known protein sequences to assign peptide identities. A single experiment can identify thousands of proteins from a cell lysate. The NIH-indexed review of mass spectrometry for proteomics traces the evolution of this approach from low-throughput manual methods to high-throughput automated platforms capable of analyzing hundreds of samples per day.

Quantitative Proteomics

Identifying which proteins are present in a sample is only the first step; understanding how protein abundances change across conditions requires quantification. Quantitative proteomics methods fall into two broad categories. Stable isotope labeling methods, including SILAC (stable isotope labeling by amino acids in cell culture) and iTRAQ (isobaric tags for relative and absolute quantitation), introduce heavy isotope-labeled versions of specific amino acids or chemical tags into samples, allowing multiple conditions to be measured in the same mass spectrometry run by comparing the intensities of differentially labeled peptide pairs. Label-free quantification methods compare peptide signal intensities or spectral counts across separately analyzed samples without chemical labeling, trading the precision of labeled approaches for greater sample flexibility. Both strategies are described in the NCBI-indexed overview of quantitative mass spectrometry-based proteomics, which covers the statistical considerations involved in detecting biologically meaningful changes.

Bioinformatics and Data Analysis

A proteomics experiment generates gigabytes of raw mass spectrometry data that must be processed through a pipeline of computational steps before biological conclusions can be drawn. Spectrum processing converts raw instrument data to peak lists; database searching assigns peptide identities; protein inference algorithms group peptides to the proteins they could have originated from; and statistical models control the false discovery rate for both peptide and protein identifications. Downstream analysis tools map identified proteins to cellular pathways, protein interaction networks, and Gene Ontology categories. Repositories such as the PRIDE database archive raw proteomics data to enable reproducibility and reanalysis, following principles analogous to those established in genomics by the Sequence Read Archive.

Applications

Proteomics has applications across a range of scientific and clinical domains, including:

• Biomarker discovery, where differential protein expression in patient versus control samples identifies candidate diagnostic or prognostic markers for disease
• Drug development, where clinical proteomics studies published in PMC demonstrate how mass spectrometry quantifies drug targets and off-target proteins to assess therapeutic mechanism
• Infectious disease research, where host and pathogen proteomes are profiled to understand infection mechanisms and identify vaccine antigens
• Structural and interactomics studies, where affinity purification coupled with mass spectrometry maps protein-protein interaction networks in intact cells